"Having walked in the shoes of parent, nurse, and physician, Dr. McMahon brings a very unique and vital perspective to our Board," said Melmark President and CEO Rita M. Gardner, M.P.H., LABA, BCBA, ...

Shares of Merck & Co. Inc. MRK inched 0.44% higher to $101.17 Thursday, on what proved to be an all-around mixed trading ...

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

Tempus AI's growth and partnerships make it an attractive investment. See why TEM stock is a solid Buy due to its ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

Welcome to the Moderna third quarter 2024 conference call. [Operator instructions] Please be advised today's conference is ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

Expanded Board of Directors with appointment of Dr. Alison Moore bringing cell therapy and manufacturing expertise to advance AlloNK® in ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

The American College of Cardiology/Association of Black Cardiologists Merck Research Fellowships provide three one ... experience directly involving patients or human subjects Have had no more than ...